Randomized controlled trialHumanClinical Trial, Phase II

Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients

International journal of colorectal disease, 2014 Dec. Beck DE, Sweeney WB, McCarter MD and 1 others.

Study type
Randomized controlled trial · Clinical Trial, Phase II
Subjects
Human participants (PubMed MeSH: Humans)
Journal
International journal of colorectal disease
Published
2014 Dec
PubMed
PMID 25331030 ↗
DOI
10.1007/s00384-014-2030-8 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Ipamorelin →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Double-Blind MethodFemaleGastrointestinal AgentsHumansIleusIntestinesMaleMiddle AgedNauseaOligopeptidesPostoperative ComplicationsProspective Studies

Other papers on Ipamorelin

Journal article · 2009
Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileus
Journal article · 1998
Ipamorelin, the first selective growth hormone secretagogue

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds